Gilead Sciences Inc (GILD)
67.72
-0.14
(-0.21%)
USD |
NASDAQ |
May 17, 16:00
67.74
+0.02
(+0.03%)
After-Hours: 20:00
Gilead Sciences Cash from Operations (TTM): 8.481B for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 8.481B |
December 31, 2023 | 8.006B |
September 30, 2023 | 8.404B |
June 30, 2023 | 9.512B |
March 31, 2023 | 8.976B |
December 31, 2022 | 9.072B |
September 30, 2022 | 9.71B |
June 30, 2022 | 10.10B |
March 31, 2022 | 10.61B |
December 31, 2021 | 11.38B |
September 30, 2021 | 10.10B |
June 30, 2021 | 9.092B |
March 31, 2021 | 9.342B |
December 31, 2020 | 8.168B |
September 30, 2020 | 8.832B |
June 30, 2020 | 9.227B |
March 31, 2020 | 9.003B |
December 31, 2019 | 9.144B |
September 30, 2019 | 8.909B |
June 30, 2019 | 8.476B |
March 31, 2019 | 7.707B |
December 31, 2018 | 8.40B |
September 30, 2018 | 8.808B |
June 30, 2018 | 9.29B |
March 31, 2018 | 11.24B |
Date | Value |
---|---|
December 31, 2017 | 11.90B |
September 30, 2017 | 12.68B |
June 30, 2017 | 14.38B |
March 31, 2017 | 15.84B |
December 31, 2016 | 17.05B |
September 30, 2016 | 19.30B |
June 30, 2016 | 19.01B |
March 31, 2016 | 19.68B |
December 31, 2015 | 21.25B |
September 30, 2015 | 18.48B |
June 30, 2015 | 18.42B |
March 31, 2015 | 16.95B |
December 31, 2014 | 12.82B |
September 30, 2014 | 10.52B |
June 30, 2014 | 7.233B |
March 31, 2014 | 4.001B |
December 31, 2013 | 3.105B |
September 30, 2013 | 3.084B |
June 30, 2013 | 3.076B |
March 31, 2013 | 3.414B |
December 31, 2012 | 3.195B |
September 30, 2012 | 3.467B |
June 30, 2012 | 3.619B |
March 31, 2012 | 3.271B |
December 31, 2011 | 3.639B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
8.006B
Minimum
Dec 2023
11.38B
Maximum
Dec 2021
9.227B
Average
9.082B
Median
Cash from Operations (TTM) Benchmarks
Bristol-Myers Squibb Co | 13.72B |
Merck & Co Inc | 14.76B |
Pfizer Inc | 8.578B |
AbbVie Inc | 22.69B |
Xilio Therapeutics Inc | -53.87M |